Posted in | News

Masonite Purchases Assets of India’s Two Leading Door Manufacturers

Masonite Inc. (the “Company”) (OTCBB: MASWF) today announced the strategic acquisition of selected assets of two leading door manufacturers in India--Feroke Boards Limited, located at Aluva near Cochin, Kerala State and Mahsim High Tech Fab Limited, located at Chanalon Industrial Area near Mohali, Punjab State. The Company is also in the advanced stages of completing a third asset acquisition in a different region of the country.

Masonite has had a strong presence in India for many years selling branded, molded door facings to door manufacturers throughout the country, including Feroke and Mahsim. These two strategic transactions allow the Company to increase its direct presence in the rapidly growing India marketplace, thus increasing the strength of the Masonite brand on a nationwide scale while enhancing our distribution network for molded door facings. The Company will also benefit from the increasing customer preference for molded interior doors.

Larry Repar, Executive Vice President and Chief Operating Officer of Masonite, stated, “The combination of the Feroke and Mahsim businesses, together with our well established independent door facing customers, will allow builders, contractors, and homeowners greater access to the wide assortment of Masonite branded and marketed products through our newly established national footprint.”

Rahul Sharma, Director of Asia Pacific for Masonite, based in New Delhi, India stated, “We are very excited about expanding our business and increasing our commitment to the Indian market. The growing demand for Masonite branded products in India will be better served by our new and expanded business strategy.”

Source: http://www.masonite.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.